tiprankstipranks
Trending News
More News >
Palisade Bio (PALI)
NASDAQ:PALI
US Market

Palisade Bio (PALI) Income Statement

Compare
617 Followers

Palisade Bio Income Statement

Last quarter (Q3 2025), Palisade Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Palisade Bio's net income was $-2.87M. See Palisade Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 250.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 250.00K$ 0.00$ 0.00$ -146.00K
Operating Expenses
$ 14.86M$ 13.32M$ 15.72M$ 41.85M$ 9.15M
Depreciation and Amortization
$ 3.00K$ 4.00K$ 3.00K$ 2.00K$ 146.00K
EBITDA
$ -14.42M$ -12.28M$ -14.24M$ -24.22M$ -9.94M
Operating Income
$ -14.86M$ -13.07M$ -15.72M$ -41.85M$ -9.30M
Other Income/Expenses
$ 421.00K$ 770.00K$ 1.46M$ 15.24M$ -1.02M
Pretax Income
$ -14.44M$ -12.30M$ -14.26M$ -26.62M$ -10.32M
Net Income
$ -14.44M$ -12.30M$ -14.26M$ -26.62M$ -10.32M
Per Share Metrics
Basic EPS
$ -10.19$ -27.01$ -16.53$ -2.14K$ -186.00
Diluted EPS
$ -10.19$ -27.01$ -16.53$ -2.55K$ -186.00
Weighted Average Shares Outstanding
1.42M 456.01K 880.10K 12.41K 832.30K
Weighted Average Shares Outstanding (Diluted)
1.42M 456.01K 880.30K 12.46K 237.39K
Currency in USD

Palisade Bio Earnings and Revenue History